Search results
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 11 hours agoHemgenix gained U.S. approval in late 2022 and also costs $3.5 million before insurance deductions...
New events, new beverage lines: Wineries adapt to survive in 2024 - Buffalo Business First
The Business Journals· 5 days agoWith age comes wisdom, and that’s certainly true among wineries on the Niagara Wine Trail, where...
Invasive Species, Somi Kakoma, Kev Berry & More To Perform At The Tank Forever! 21 Gala
Broadway World· 7 days agoCatch performances by Invasive Species, Somi Kakoma, Kev Berry, and more at The Tank Forever! 21 Gala this month. Learn more about the performances, and see how to purchase tickets.
New Technology Puts Financial Improvements on the Menu for Restaurants
PYMNTS.com· 2 days agoA report from Fiserv went into more detail. The Fiserv Small Business Index showed that small...
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3...
Morningstar· 7 days agoFN Media Group News Commentary - There is much activity in finding better ways in mitigating muscle loss for the cancer patients… many clinical studies are looking for elite performance nutritional ...
Travis Kelce lines up another TV job and joins FX’s ‘Grotesquerie’ from Ryan Murphy
Waterloo-Cedar Falls Courier· 6 days agoThe Kansas City Chiefs tight end Travis Kelce, famous boyfriend of superstar Taylor Swift, is...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 2 days agoTendon Allograft Market to Reach $42.7 Billion Globally by 2032 at 5.2% CAGR: Allied Market Research PR Newswire PORTLAND, Ore., May 13, 2024 The increasing focus on sports ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 1 day ago— Almost half a million people diagnosed each year across the globe — — Collaboration based on synergistic potential of inhibiting angiogenesis and tumor-associated macrophages with HUTCHMED’s surufatinib and anti-PD-1 activity with Hengrui’s
Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and...
WTNH-TV New Haven· 7 days agoSyndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an...
Biden says US won't supply weapons for Israel to attack Rafah, in warning to ally
Sioux City Journal· 6 days agoPresident Joe Biden said Wednesday he would not supply offensive weapons that Israel could use to...